Respiratory infections multiplex, nucleic acid detection
Scheme information
Service
EQAS
Scheme
Respiratory infections multiplex, nucleic acid detection
Service provider
Labquality
Accreditation
Not accredited
Status
New scheme in 2018
Target
Laboratories
Coverage
Analytical phase
Rounds
2
Distributions
Europe, the Middle East and Asia
Coordinator
Jaana Paakkanen
Expert
Matti Waris
Products
5300 / Respiratory infections multiplex, nucleic acid detection
Samples: 4 simulated samples, ≥ 0.5mL each
Type: Physical
Examinations: Direct multiplex nucleic acid detection. Pathogens included are C. pneumoniae, M. pneumoniae, B. pertussis, B. parapertussis, influenza A/B, RSV A/B, human rhinovirus, enterovirus, parainfluenza, human metapneumovirus, adenovirus and coronavirus.
Additional information: Pathogens are covered during annual scheme: participation to all rounds required